Age dependence of diphenylcyclopropenone sensitization in patients with alopecia areata.
Contact sensitization has been an accepted topical immunotherapy in the treatment of alopecia areata (1, 2). Whether the age of patients is a significant factor in the treatment results is a matter of controversy. In our study, we investigated the correlation between age of the patients and diphenylcyclopropen-one contact sensitization in vivo and in vitro (3, 4).
National Institute of Dermato-Venereology, Hungary.
Erzsébet
E
Temesvári
Rhenso
R
González
Márta
M
Marschalkó
Attila
A
Horváth
D000328:Adult; D000367:Age Factors; D000506:Alopecia Areata / Q000628:therapy*; D003521:Cyclopropanes / Q000276:immunology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged
D003521:Cyclopropanes; C047607:diphenylcyclopropane